Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists. The risk is almost 5 times higher with Wegovy than it is with Ozempic, and 3 times greater in men than it is in women.
· 黄磊 · 来源:user门户
一文读懂Wegovy may have highest ‘eye stroke’ and sight loss risk of semaglutide GLP-1 agonists. The risk is almost 5 times higher with Wegovy than it is with Ozempic, and 3 times greater in men than it is in women.:从基本概念到实际应用,为您系统梳理最新进展。